Staphylococcal Infections: all 278 studies

Page 1 of 3. Open to participants first (29), then studies with results posted, then the rest; newest registration first within each.

• Bacterial Decolonization to Prevent Severe Radiation Dermatitis in Head and Neck Squamous Cell CarcinomaNot yet recruitingNCT07888907Not applicable
• Secondary Bacterial Infections and Nasal Colonization in Scabies and Atopic DermatitisNot yet recruitingNCT07813611
• Intertriginous/Periorificial Dermatoses in Patients With IBD on Anti-TNFα: Relative Abundance of Staphylococcus Aureus Within the Lesion Microbiota and Clinical Correlation (micSPIDER).Not yet recruitingNCT07812675
• Population Pharmacokinetic Model of Rifampicin in Staphylococcal Osteoarticular InfectionsRecruitingNCT07788404Not applicable
• Thermosensitive Gel Nasal Spray With Stem Cell Exosomes, Mupirocin, and DNase I for Chronic SinusitisNot yet recruitingNCT07635433Early Phase 1
• Adjuvant Clopidogrel in Staphylococcus Aureus BacteremiaNot yet recruitingNCT07384702Phase 2
• Rifampin-free Regimen Versus Rifampin-containing Regimen in the Treatment of Staphylococcal Prosthetic Valve EndocarditisRecruitingNCT07345325Phase 3
• Retention of Vernix Caseosa in Newborns for Primary Prevention of Atopic DermatitisRecruitingNCT07333378Not applicable
• Safety of Combined Intravenous Antibiotic and Bacteriophage Therapy in Adults With Cystic Fibrosis and Antibiotic-Resistant Lung InfectionsNot yet recruitingNCT07280598Phase 1
• Linezolid Plus Standard of CareRecruitingNCT06958835Not applicable
• NAsal MEthicillin-resistant Staphylococcus (NAMES): a Prospective Study to Assess the Impact of Antibiotic Therapy on Nasal Colonization with Methicillin-resistant Staphylococcus Aureus (MRSA) Inhospitalized ChildrenRecruitingNCT06872099
• Unbound Cloxacillin Concentrations During Continuous InfusionRecruitingNCT06848387Phase 4
• Administering NMT to Reestablish Infant Nasal Microbiome Diversity Following Intranasal Mupirocin TreatmentRecruitingNCT06805994Phase 1
• Identification and Validation of Clinical Phenotypes in Staphylococcus Aureus Bacteremia and Their Association With Mortality and Development of Complicated BacteremiaRecruitingNCT06574399
• Plasma Pharmacological Monitoring of M Penicillins in Methicillin-sensitive Staphylococcus Aureus BacteremiaRecruitingNCT06495697
• Modeling Host-Pathogen Interaction Using Lymphoid OrganoidsRecruitingNCT06479837
• Echocardiography Versus no Echocardiography in S. Aureus Bacteraemia and VIRSTA Score < 3RecruitingNCT06457386Not applicable
• Early Intravenous to Oral Antibiotic Switch in Uncomplicated Staphylococcus Aureus BacteraemiaRecruitingNCT06336824Phase 3
• Clinical Trial to Demonstrate the Safety and Efficacy of DUOFAG®RecruitingNCT06319235Phase 1/2
• Effectiveness of Highly Purified Anhydrous (HPA) Lanolin Versus Extra-Virgin Coconut Oil in Preventing Subacute Lactation MastitisEnrolling by invitationNCT06317688Phase 1
• Adjunctive Clindamycin for the Treatment of Skin and Soft Tissue Infections, a Randomized Controlled TrialRecruitingNCT05899140Phase 4
• Evaluation of the Usefulness of Echocardiography in Patients With Staphylococcus Aureus Bacteremia (ET-AUREUS Study).RecruitingNCT05862025Not applicable
• Target Attainment of Continuous Infusion Flucloxacillin and Cefazolin Coupled With TDM vs. Standard of Care Treatment in Patients With Complicated S. Aureus InfectionRecruitingNCT05655091Phase 2
• 18-fluorodeoxyglucose Positron Emission Tomography/Computed Tomography in S. Aureus BacteraemiaNot yet recruitingNCT05361135Not applicable
• Staphylococcus Aureus Network Adaptive Platform TrialRecruitingNCT05137119Phase 4
• Dalbavancin Versus Standard Antibiotic Therapy for Catheter-related Bloodstream Infections Due to Staphylococcus AureusRecruitingNCT05117398Phase 3
• Serum Based Diagnosis of and Monitoring of Infection Recovery in Orthopedic Spine Implant InfectionsEnrolling by invitationNCT04897971
• Combination Cefazolin With Ertapenem for Methicillin-susceptible Staphylococcus Aureus BacteremiaRecruitingNCT04886284Phase 2
• Standard Treatment Associated With Phage Therapy Versus Placebo for Diabetic Foot Ulcers Infected by S. AureusNot yet recruitingNCT02664740Phase 1/2
• Study Evaluating Safety, Tolerability, and Efficacy of Intravenous AP-SA02 in Subjects With S. Aureus BacteremiaCompletedNCT05184764Phase 1/2Results posted
• DOTS: Dalbavancin as an Option for Treatment of Staphylococcus Aureus BacteremiaCompletedNCT04775953Phase 2Results posted
• Direct Lysis of Staph Aureus Resistant Pathogen Trial of ExebacaseTerminatedNCT04160468Phase 3Results posted
• Effect of Exeporfinium Chloride (XF-73) Gel on Nasal S.Aureus in Patients at Risk of Post-op Staphylococcal InfectionCompletedNCT03915470Phase 2Results posted
• A Study to Evaluate the Safety, PK, PD, Immunogenicity of N-Rephasin® SAL200 in Healthy Male VolunteersCompletedNCT03446053Phase 1Results posted
• Preventing the Spread of Infection in Nursing HomesCompletedNCT03319368Not applicableResults posted
• Safety, Efficacy and Pharmacokinetics of CF-301 vs. Placebo in Addition to Antibacterial Therapy for Treatment of S. Aureus BacteremiaCompletedNCT03163446Phase 2Results posted
• Ceftobiprole in the Treatment of Patients With Staphylococcus Aureus BacteremiaCompletedNCT03138733Phase 3Results posted
• Phase IIa Clinical Study of N-Rephasin® SAL200TerminatedNCT03089697Phase 2Results posted
• Staph Household Intervention for Eradication (SHINE)CompletedNCT02572791Phase 4Results posted
• SA4Ag Safety, Tolerability, and Immunogenicity Study in Japanese AdultsCompletedNCT02492958Phase 2Results posted
• Safety & Efficacy of True Human Antibody, 514G3, in Staphylococcus Aureus Bacteremia Hospitalized Subjects.CompletedNCT02357966Phase 1/2Results posted
• Ceftaroline for Treatment of Hematogenously Acquired Staphylococcus Aureus Osteomyelitis in ChildrenCompletedNCT02335905Phase 1/2Results posted
• Study to Assess Eradication of Nasal Carriage of Staphylococcus Aureus (SA) With Mupirocin (Bactroban 2% Nasal Ointment)CompletedNCT02284555Phase 4Results posted
• Study of the Nasal Decolonisation of Staphylococcus Aureus (SA) and the Safety and Tolerability of XF-73 Nasal Gel in Healthy SubjectsCompletedNCT02282605Phase 1/2Results posted
• Treating Parents to Reduce NICU Transmission of Staphylococcus Aureus TrialCompletedNCT02223520Not applicableResults posted
• A Study to Evaluate the Safety, Pharmacokinetics and Pharmacodynamics of N-Rephasin® SAL200 in Healthy Male VolunteersCompletedNCT01855048Phase 1Results posted
• Safety and Efficacy of Mupirocin in Eradicating Colonization With S. Aureus in Critically Ill InfantsCompletedNCT01827358Phase 2Results posted
• Chlorhexidine Gluconate Cleansing in Preventing Central Line Associated Bloodstream Infection and Acquisition of Multi-drug Resistant Organisms in Younger Patients With Cancer or Undergoing Donor Stem Cell TransplantCompletedNCT01817075Phase 3Results posted
• Prospective Evaluation of a Vancomycin Nomogram With a Continuous Infusion of Vancomycin for Surgical ICU PatientsTerminatedNCT01786161Phase 4Results posted
• Evaluation of Patients With Methicillin-Resistant Staphylococcus Aureus Hospital-Acquired Pneumonia Treated With Linezolid or VancomycinCompletedNCT01561469Results posted
• Randomized Controlled Trial of Antibiotics in the Management of Children With Community-Acquired AbscessTerminatedNCT01498744Not applicableResults posted
• Retapamulin for Reducing MRSA Nasal CarriageCompletedNCT01461668Phase 4Results posted
• Effect of Adjuvant & Route of Administration on Safety & Immunogenicity of NDV-3 VaccineCompletedNCT01447407Phase 1Results posted
• Early Methicillin-resistant Staphylococcus Aureus (MRSA) Therapy in Cystic Fibrosis (CF)TerminatedNCT01349192Phase 2Results posted
• Safety, Tolerability, and Immunogenicity of a Single Dose of Merck 0657nI Staphylococcus Aureus Vaccine With or Without Merck Aluminum Adjuvant (V710-002)CompletedNCT01324440Phase 1Results posted
• Methicillin-resistant Staphylococcus Aureus (MRSA) Skin and Soft Tissue Infection (SSTI) Prevention in Military TraineesCompletedNCT01105767Not applicableResults posted
• Staphylococcus Aureus Toxoids Phase 1-2 Vaccine TrialCompletedNCT01011335Phase 1/2Results posted
• Clearance of Nasal Staphylococcus Aureus With Triple Antibiotic OintmentCompletedNCT00997139Not applicableResults posted
• Cluster Randomized Trial of Hospitals to Assess Impact of Targeted Versus Universal Strategies to Reduce Methicillin-resistant Staphylococcus Aureus (MRSA) in Intensive Care Units (ICUs)CompletedNCT00980980Not applicableResults posted
• Epidemiology and Prevention of Methicillin Resistant Staphylococcus Aureus (MRSA) Transmission in the CommunityCompletedNCT00966446Not applicableResults posted
• Prevention of Recurrent Infections Caused by Community Acquired Staphylococcus Aureus (CA-SA) in ChildrenCompletedNCT00901316Not applicableResults posted
• Rifabutin Based Therapy for the Eradication of Staphylococcus Aureus Colonization in HIV Infected AdultsTerminatedNCT00869518Phase 2Results posted
• Trial of Septra for Uncomplicated Skin Abscesses in Patients at Risk for Community Acquired Methicillin-Resistant Staphylococcus Aureus InfectionCompletedNCT00822692Not applicableResults posted
• Cost-Effectiveness Study Comparing Chlorhexidine Bathing With Active Surveillance Cultures to Prevent Methicillin-resistant Staphylococcus Aureus & Other Hospital InfectionsCompletedNCT00779246Not applicableResults posted
• A Study of MK-3009 in Japanese Patients With Skin or Blood Stream Infections Caused by Methicillin-resistant Staphylococcus Aureus (MK-3009-002)CompletedNCT00770341Phase 3Results posted
• V710 Clinical Study in Healthy Male Japanese Subjects (V710-006) (COMPLETED)CompletedNCT00735839Phase 1Results posted
• Staphylococcus Aureus Decolonization StudyCompletedNCT00731783Not applicableResults posted
• Uncomplicated Skin and Soft Tissue Infections Caused by Community-Associated Methicillin-Resistant Staphylococcus AureusCompletedNCT00730028Phase 2Results posted
• Strategies Using Off-Patent Antibiotics for Methicillin Resistant S. Aureus "STOP MRSA"CompletedNCT00729937Phase 2/3Results posted
• Drug Use Investigation Of Zyvox (Linezolid) (Regulatory Post Marketing Commitment Plan)CompletedNCT00666276Results posted
• Safety and Efficacy of Pagibaximab Injection in Very Low Birth Weight Neonates for Prevention of Staphylococcal SepsisCompletedNCT00646399Phase 2/3Results posted
• Prospective Study of Methicillin-Resistant Staphylococcus Aureus (MRSA) Among HIV-Infected PersonsCompletedNCT00631566Not applicableResults posted
• A Study to Evaluate the Safety and Immunogenicity of V710 in Adults With Kidney Disease on Hemodialysis (V710-005)(COMPLETED)CompletedNCT00572910Phase 2Results posted
• Hospital Design and Risk of Nosocomial Infections: A Prospective Controlled TrialCompletedNCT00563186Not applicableResults posted
• Comparison of Cephalexin Versus Clindamycin for Suspected CA-MRSA Skin InfectionsCompletedNCT00352612Phase 4Results posted
• V710 First-In-Man (FIM) Study (V710-001)CompletedNCT00303069Phase 1Results posted
• The Impact of Treating Staphylococcus Aureus Infection and Colonization on the Clinical Severity of Atopic DermatitisCompletedNCT00179959Phase 4Results posted
• Preventing Staphylococcal (Staph) InfectionCompletedNCT00108160Phase 4Results posted
• Comparison of Telavancin and Vancomycin for Complicated Skin and Skin Structure Infections With a Focus on Methicillin-resistant Staphylococcus AureusCompletedNCT00107978Phase 3Results posted
• Skin Structure Infections With Suspected or Proven Methicillin-Resistant Staphylococcus Aureus (MRSA)CompletedNCT00087490Phase 4Results posted
• Nosocomial Pneumonia With Suspected Or Proven Methicillin-Resistant Staphylococcus Aureus (MRSA)CompletedNCT00084266Phase 4Results posted
• Amoxicillin/Clavulanic Acid Susceptibility in Acute Community-acquired Pneumonia Requiring Intensive Care ManagementCompletedNCT07322549
• Investigation of Antibacterial Effect of Levobupivacaine on Staphylococcus AureusCompletedNCT07285759Not applicable
• Light-Activated Antimicrobial Therapy to Prevent Surgical Site Infections - CanadaCompletedNCT07189858Not applicable
• Staphylococcus Haemolyticus in the Neonatal Intensive Care Unit of CHSD in 2023: Analysis and TrendsCompletedNCT07013864
• Comparative Analysis of Nemonoxacin and Other Anti-methicillin Resistant Staphylococcus Aureus (Anti-MRSA) Antimicrobial Therapy in Patients With Complicated Skin and Soft Tissue Infections (cSSTI): a Retrospective Chart Review StudyActive, not recruitingNCT06959667
• A Study to Evaluate AZD7760 Safety and Pharmacokinetics in Healthy Adults (Phase I) and Adults With End-stage Kidney Disease on Hemodialysis With a Central Venous Catheter (Phase IIa)Active, not recruitingNCT06749457Phase 1/2
• Light-Activated Antimicrobial Therapy to Prevent Surgical Site InfectionsCompletedNCT06702878Phase 3
• Adjunctive Fosfomycin for Treatment of Staphylococcus Aureus BacteraemiaActive, not recruitingNCT06695832
• Decolonization Efficacy of Polyhexanide vs. MupirocinCompletedNCT06633588Phase 4
• Bacteriophage Therapy for Methicillin-Sensitive Staphylococcus Aureus Prosthetic Joint InfectionActive, not recruitingNCT06456424Phase 1/2
• Pharmacology of Mupirocin in Nasal Application in Healthy Volunteers: Monocentric StudyActive, not recruitingNCT06368856Phase 1
• Studying the Distribution of Accessory Gene Regulator (Agr) Quorum Sensing System and the Prevalence of Linezolid and Mupirocin Resistance in Biofilm Producer/Non Producer Staphylococcus Aureus in Sohag University HospitalsCompletedNCT06291181Not applicable
• Comparing Single Versus Repeat NMT on the Diversity of the Neonatal Nasal MicrobiomeActive, not recruitingNCT06283355Phase 1
• Staphylococcus Aureus Bacteraemia (SAB)-Support-StudyCompletedNCT06249451Not applicable
• Staph Intervention for Effective Local DefenseCompletedNCT06210594Phase 4
• Study to Evaluate the Efficacy, Safety and Tolerability of 3% LTX-109 for Nasal Decolonisation of Staphylococcus AureusCompletedNCT05889351Phase 2
• Feasibility and Safety Study of Parent-to-Child Nasal Microbiota TransplantActive, not recruitingNCT05695196Phase 1
• ERAdicate S. Aureus in Patients With Bacteremia and EndocarditisWithdrawnNCT05329168Phase 2
• Rifampicin Resistance in S. Aureus During and After Treatment for Latent TuberculosisActive, not recruitingNCT05073926

← Staphylococcal Infections overview